drugset / Trial / NCT01278394

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail

NCT01278394

Phase 2 Completed 29 enrolled Pfizer
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to determine the safety and efficacy of 5.0% AN2690 Solution in the treatment of distal, subungual onychomycosis of the great target toenail.

Timeline

Start
2007-03
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tavaborole Small molecule 5 % Topical

Indications